Neurelis
is a California-based pharmaceutical company that researches and develops novel drugs for the treatment of central nervous system disorders... Read moreNeurelis
is a California-based pharmaceutical company that researches and develops novel drugs for the treatment of central nervous system disorders... Read more
News
May 12, 2026
PR Newswire
Press Release: Neurelis : Trinity's TGaS Advisors Announces Winners of 9th Annual Best of Benchmark Awards
Apr 23, 2026
PR Newswire
Press Release: Neurelis : NEURELIS HELPS SUPPORT NATIONAL NETWORK OF EPILEPSY AWARENESS AND SUPPORT AT FIRST EPILEPSY AWARENESS DAY AND EDUCATION EXPO AT WALT DISNEY WORLD
Apr 16, 2026
PR Newswire
Press Release: Neurelis : NEURELIS TO PRESENT ANALYSES OF IMMEDIATE-USE SEIZURE TREATMENT AT THE AMERICAN ACADEMY OF NEUROLOGY ANNUAL MEETING
Dec 05, 2025
PR Newswire
Press Release: Neurelis : NEURELIS TO PRESENT CLINICAL DATA AT AMERICAN EPILEPSY SOCIETY ANNUAL MEETING
Nov 10, 2025
PR Newswire
Press Release: Neurelis : NEURELIS TO PARTICIPATE IN SOFIE'S JOURNEY EPILEPSY AWARENESS DAY AND EDUCATION EXPO AT DISNEYLAND RESORT
Apr 17, 2025
Pharamceutical Technology
Neurelis: FDA approves Neurelis' nasal spray for seizures
Apr 07, 2025
PR Newswire
Press Release: Neurelis : NEURELIS WILL HIGHLIGHT ANALYSES OF SEIZURE TREATMENT WITH DIAZEPAM NASAL SPRAY AT THE AMERICAN ACADEMY OF NEUROLOGY ANNUAL MEETING
Dec 06, 2024
StreetInsider
Press Release: Neurelis : NEURELIS PRESENTS STUDIES ON SEIZURE CLUSTERS AT THE AMERICAN EPILEPSY SOCIETY ANNUAL MEETING
Nov 19, 2024
StreetInsider
Press Release: Neurelis : NEURELIS TO JOIN EPILEPSY COMMUNITY AT 12TH ANNUAL SOFIE'S JOURNEY EPILEPSY AWARENESS DAY AND EDUCATION EXPO AT DISNEYLAND RESORT
Nov 14, 2024
Benzinga
Neurelis: NEURELIS ENTERS $208 MILLION AGREEMENT TO MONETIZE INTRAVAIL ROYALTIES
Neurelis Competitors
1
2
3
4
5
6
7
8
9
10